Search This Blog

Thursday, January 12, 2023

Dollar General to offer mobile clinics in Middle Tennessee

 Dollar General has announced three of its stores in Middle Tennessee now offer mobile health clinics to provide customers with basic health care.

Its services, provided by DocGo On-Demand, are available Sundays and Monday at the Dollar General on Highway 48 in Clarksville; on Wednesdays and Thursdays at the store on Ashland City Road in Clarksville; and on Fridays and Saturdays at the store on Highway 48 in Cumberland Furnace.

The clinic is open from 10 a.m. to 8 p.m. each day. Dollar General and DocGo plan to evaluate customer response and decide whether to expand the program, according to a media release.

Dollar General is opening a mobile clinic that will visit three locations in Montgomery and...
Dollar General is opening a mobile clinic that will visit three locations in Montgomery and Dickson counties.(WSMV)

“We’re excited to pilot new mobile health clinics with services provided by DocGo On-Demand to provide services including annual physicals, acute illness, urgent care needs, vaccinations and lab testing,” said Dr. Albert Wu, Dollar General’s chief medical officer, in the media release. “These clinics demonstrate our ability and desire to work with our customers to bring affordable health and wellness closer to home while equally establishing Dollar General as a trusted partner where customers can access health services.”

Customers interested in seeing a DocGo On-Demand professional can schedule an appointment on the Dollar General Well Being website or call 1-844-443-6246. Walk-in services are also available.

DocGo On-Demand currently accepts Medicaid/TennCare, Medicare, and select plans from major insurance companies. A cash option is also available.

https://www.wsmv.com/2023/01/11/dollar-general-offer-mobile-clinics-middle-tennessee/

What Damar Hamlin's Cardiac Workup Might Look Like

 Almost 2 weeks after Damar Hamlin suffered a cardiac arrest

opens in a new tab or window during a Monday Night Football game, the underlying cause that triggered his condition has yet to be revealed -- but that's because his doctors have to conduct an extensive workup involving several possibilities.

Cardiologists and electrophysiologists who were not involved in Hamlin's care outlined those possibilities in interviews with MedPage Today.

Since Hamlin's case was witnessed by so many peopleopens in a new tab or window, that helps narrow the diagnoses a bit, said Zian Tseng, MD, a cardiologist and cardiac electrophysiologist at the University of California San Francisco. Hamlin had a "documented rhythm of ventricular fibrillation and was then shocked for it, that really does help narrow it down that it was an arrhythmia-related cardiac arrest," he said.

In a case like this, doctors would take a complete history and physical, noting whether the patient had any prior symptoms, such as chest pain, shortness of breath, or fainting. Doctors would also determine if the patient was taking any medications or supplements.

Meagan Wasfy, MD, MPH, a sports cardiologist at Massachusetts General Brigham in Boston, said an analogy for how physicians would approach a case like this would be to think of the heart as a house. They must check the plumbing (the arteries), structural issues, and the electrical system.

"The evaluation really has to look at all the potential systems that can contribute to a sudden cardiac arrest event," Wasfy said.

Physicians might first consider ischemic heart disease, such as a myocardial infarction, as a potential cause, as well as dissection or spasm of the arteries or some other kind of congenital anomaly in the heart's blood vessels.

"Any coronary artery-related or ischemic heart disease would be one big thing to rule out," Tseng said.

Next, doctors would look for structural problems, such as hypertrophic cardiomyopathy or any increased thickness or dilation of the heart, along with any valvular problems.

"Sometimes that may require not just an echocardiogram, but an MRI, to rule out more subtle things like myocarditis, or cardiac sarcoidosis, or any kind of infiltrative disease," Tseng said.

If those tests don't reveal anything, then electrical problems need to be considered, he said.

A baseline electrocardiogram (ECG) can reveal conditions that may predispose someone to sudden cardiac arrest, such as Wolff-Parkinson-White (WPW) syndrome, long QT syndrome, or Brugada syndrome, he said.

If the patient is negative for all of those conditions, "then we go down the pathway of looking for rare electrical causes," he said, which involves an exercise test or an electrophysiology study "where we do programmed electrical testing ... to try to reproduce the ventricular fibrillation or the ventricular tachycardia."

It's possible that some patients may have genetic testing to find something extremely unusual, such as an "unrecognized channelopathy," Tseng said, but doctors tend to be cautious about these results.

Kiran Musunuru, MD, PhD, MPH, a cardiologist and cardiovascular genetics expert at the University of Pennsylvania, said the challenge with genetic testing is that it could yield false-positive results or variants of uncertain significance.

That "could lead to unnecessary testing and to undue stress for the patient and their family members," Musunuru said.

Nonetheless, it's unlikely an NFL player would be allowed to return to play unless every diagnosis has been ruled out, Tseng added.

If all of these pathways are explored and nothing turns up a positive finding, then doctors can consider concluding that Hamlin's cardiac arrest was indeed caused by commotio cordis, that rare condition in which cardiac arrest occurs after a blunt force trauma to the chest at a specific time during the heart's beating cycle.

Tseng said the episode did look "very consistent with chest wall trauma."

"If everything is negative and all you're left with is, he collapsed on the field and had ventricular fibrillation, and right before that he had this really violent tackle -- I think that would be consistent with commotio cordis," Tseng said.

Yet he warned that it's a "tall order" to rule out all possibilities; to make sure Hamlin hasn't had previous chest pain or fainting, that the ECG is completely normal; that a full electrical study yields no abnormalities. It would also be "dangerous" to conclude commotio cordis and "miss something else that might be able to recur and cause another cardiac arrest."

Wasfy echoed those sentiments. She said that going into an evaluation with any type of bias "leaves you at risk for not recognizing any other potential contributors. You have to keep an open mind and be thorough, thoughtful, and methodical about the evaluation."

She noted that "being able to rest on a diagnosis of exclusion is extremely nuanced ... and is up to the medical team that knows all the details."

If it is indeed commotio cordis, only a "perfect storm" could have led to the event, Tseng said. "There's a small window in your electrical activation and recovery period where your heart is particularly vulnerable to inducing [ventricular fibrillation], and that's at the peak of the T wave. It's something like 20 milliseconds out of a typical 1,000 milliseconds of your heartbeat."

"You have to time it to that 0.2% of your heart cycle, and the force has to be enough to reach the heart, and it has to be right over the heart," he said. That's probably why it's not commonly seen in football, he said.

And even if the diagnosis ends up being commotio cordis, said Tseng, that doesn't mean there isn't something else going on with the heart that could have increased susceptibility to another event.

"Any sort of underlying condition could make somebody more prone to commotio cordis events," he said. "It doesn't mean that they can't both be true."

Tseng is the founder and primary investigator of the NIH-funded "postmortem systematic investigation of sudden cardiac death" (POST SCD) study, which investigates the underlying cause of every single sudden cardiac death in the county of San Francisco. Among its most seminal findingsopens in a new tab or window is that nearly half of presumed cardiac deaths were not indeed cardiac-related on autopsy.

https://www.medpagetoday.com/special-reports/exclusives/102605

Bivalent COVID Vaccines Likely Thwarted by Immune Imprinting: Offit

 Omicron-targeting bivalent boosters likely conferred no extra protection against COVID-19 over the original mRNA products due to immune imprinting, according to vaccine expert Paul Offit, MD, of the Children's Hospital of Philadelphia.

And by the time 10% of the U.S. population had received one of the newly authorized boosters, which were designed to target the ancestral SARS-CoV-2 strain along with BA.4 and BA.5, newer more immune-evasive variants were already outpacing the BA.4/5 Omicron subvariants, Offit pointed out in a New England Journal of Medicineopens in a new tab or window (NEJM) perspective piece.

Offit, who early last summer was one of just two members of FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) to vote against the updated boosters

opens in a new tab or window, cited lab data from a pair of studies published simultaneously in the NEJM demonstrating that antibody responses against BA.4/5 on pseudovirus assays were not significantly greater with a bivalent booster when compared with an additional dose of an original mRNA vaccine.

So why did the strategy for increasing BA.4 and BA.5 neutralizing antibodies with a bivalent vaccine fail? "The most likely explanation is imprinting," said Offit.

"The immune systems of people immunized with the bivalent vaccine, all of whom had previously been vaccinated, were primed to respond to the ancestral strain of SARS-CoV-2," he explained. "They therefore probably responded to epitopes shared by BA.4 and BA.5 and the ancestral strain, rather than to new epitopes on BA.4 and BA.5."

In the first of the studies

opens in a new tab or window, David Ho, MD, of Columbia University Vagelos College of Physicians and Surgeons in New York City, and colleagues, collected serum samples from 40 individuals who received three monovalent mRNA shots plus either a fourth dose (with either the bivalent or monovalent vaccine) and compared neutralizing-antibody levels against the ancestral strain and a host of Omicron subvariants. Across all strains, including BA.4/BA.5, Ho's group found that the bivalent boosters "did not elicit a discernibly superior virus-neutralizing peak antibody response as compared with boosting with the original monovalent vaccines."

Similarly, a studyopens in a new tab or window involving 33 participants from Dan Barouch, MD, PhD, of Beth Israel Deaconess Medical Center in Boston, and colleagues reported on immunogenicity against BA.5 in 33 people, finding that "median BA.5 neutralizing antibody titer was similar after monovalent and bivalent mRNA boosting, with a modest trend favoring the bivalent booster by a factor of 1.3."

The two research groups also offered immune imprinting as a possible hurdle to success with variant-specific vaccines.

According to Barouch's group, "immune imprinting by previous antigenic exposure may pose a greater challenge than is currently appreciated for inducing robust immunity against SARS-CoV-2 variants."

Offit suggested that using BA.4/5 mRNA components alone, or with a greater quantity of BA.4/5-targeted mRNA, may have better elicited the intended goal. He cited earlier Pfizer-BioNTech dataopens in a new tab or window on the companies' Omicron BA.1-containing vaccines (which VRBPAC rejected) that showed greater BA.1-specific neutralizing-antibody responses with monovalent BA.1 vaccines or with a higher-dose (60 μg) bivalent vaccines compared to a lower-dose (30 μg) bivalent shot.

"Fortunately," he said, "SARS-CoV-2 variants haven't evolved to resist the protection against severe disease offered by vaccination or previous infection. If that happens, we will need to create a variant-specific vaccine."

"Although boosting with a bivalent vaccine is likely to have a similar effect as boosting with a monovalent vaccine, booster dosing is probably best reserved for the people most likely to need protection against severe disease -- specifically, older adults, people with multiple coexisting conditions that put them at high risk for serious illness, and those who are immunocompromised," Offit argued. "In the meantime, I believe we should stop trying to prevent all symptomatic infections in healthy, young people by boosting them with vaccines containing mRNA from strains that might disappear a few months later.

Infectious disease specialist and epidemiologist Celine Gounder, MD, ScM, a senior fellow at the Kaiser Family Foundation, told MedPage Today that "there may be value in giving a booster to certain populations at certain times of year, or in certain settings to reduce the risk of infection and transmission.

"While COVID vaccination doesn't prevent infection and transmission 100%, even a 20% reduction in risk can be profound in the right population, at the right time, and in the right place," Gounder said.

According to the science presented in these studies, she added, two full-doses of an Omicron-specific monovalent vaccine would be much more effective than the single half-dose that's in the bivalent booster. "This might have been a good option for vulnerable populations in need of the strongest practically achievable protection."

Imprinting deserves greater attention, Gounder added. "Because the bivalent boosters are a 50-50 blend of the ancestral and BA.4/5 vaccines," she said, "only a half-dose of Omicron-specific vaccine is being administered."

"These points are why we and colleagues have arguedopens in a new tab or window that the updated boosters may be at best minimally better at eliciting neutralizing antibodies against BA.4/5 compared to the original vaccines," said Gounder.

Disclosures

Offit had nothing to disclose.

Ho reported consulting and relationships with Brii Biosciences, RenBio, TaiMed Biologics, Vicarious Surgical, and WuXi Biologics. Co-authors reported relationships with Access Bio, the National Institute of Allergy and Infectious Diseases (NIAID), Healgen Scientific, Janssen, and the NIH.

Barouch reported grants and consulting for Alkermes, Avidea, BARDA, the Bill and Melinda Gates Foundation, Celsion, CureVac, DARPA, Gilead, the Henry Jackson Foundation, Intima Biosciences, Janssen, Laronde, Legend Biotech, Massachusetts Consortium on Pathogen Readiness, Meissa, MRC, Musk Foundation, NIH, Pfizer, Pharm-Olam, Ragon Institute, Regeneron, Sanofi Pasteur, SQZ Biotech, Sterne Kessler, Vector Sciences, and Zentalis, along with patents with Janssen. A co-author reported grants and contracts with NIAID.

Primary Source

New England Journal of Medicine

Source Reference: opens in a new tab or windowOffit PA "Bivalent Covid-19 vaccines -- a cautionary tale" N Engl J Med 2023; DOI: 10.1056/NEJMp2215780.

Secondary Source

New England Journal of Medicine

Source Reference: opens in a new tab or windowWang Q, et al "Antibody response to omicron BA.4–BA.5 bivalent booster" N Engl J Med 2023; DOI: 10.1056/NEJMc2213907.

Additional Source

New England Journal of Medicine

Source Reference: opens in a new tab or windowBarouch DH, et al "Immunogenicity of BA.5 bivalent mRNA vaccine boosters" N Engl J Med 2023; DOI: 10.1056/NEJMc2213948.


https://www.medpagetoday.com/infectiousdisease/covid19vaccine/102604

Healthcare-Related Injury Found in Nearly One-Fourth of Hospitalizations

 Nearly a quarter of hospital stays involve adverse events from healthcare errors, and nearly one in 10 cause serious harm, according to a study replicating the landmark 1991 Harvard Medical Practice Study

opens in a new tab or window (HMPS).

In a random sample of 2,809 admissions at 11 Massachusetts hospitals, 23.6% had at least one adverse event, 32.3% of which required substantial intervention or prolonged recovery, David W. Bates, MD, of Brigham and Women's Hospital in Boston, and colleagues reported in the New England Journal of Medicineopens in a new tab or window.

Fully 22.7% of the adverse events were judged to be preventable, with a preventable event happening in 6.8% of all admissions and a serious, life-threatening, or fatal preventable event in 1.0%.

These "disturbing" new findings "suggest that the safety movement has, at best, stalled," said Donald M. Berwick, MD, MPP, of the Institute for Healthcare Improvement in Boston, in an accompanying editorialopens in a new tab or window.

After the publication of the 2000 Institute of Medicine report "To Err Is Human: Building a Safer Health System,"opens in a new tab or window built in large part on the 1991 HMPS data, improving patient safety was a priority in U.S. healthcare for a while, Berwick noted, but the decades that followed brought inklings of progress without a firm answer on whether the national healthcare system is safer since the report rang the alarm.

The study by Bates and co-authors doesn't provide the definitive answer either, Berwick argued, as the methods differed sufficiently from the original to make direct comparison "tempting but ... not warranted."

The new study, like the one in 1991, randomly sampled admissions but added a trigger tool to help flag suspicious records and looked at certain types of harm that were not examined in the original, such as diagnostic errors and failure to treat decompensating patients. And, of course, the harder one looks for harm, the more one will find, Berwick noted.

In the 1991 HMPS, the rate of adverse events due to medical management seen in the 51 New York State hospitals evaluated was 3.7%, with 27.6% deemed due to negligence.

Also, "judging 'preventability' is not only difficult but may also be misleading," Berwick wrote. "The more valuable approach is to regard all injuries as potentially preventable." Nor did either iteration of the HMPS pay attention to "near misses."

Bates and co-authors also acknowledged that many aspects of healthcare have changed over the past 34 years (i.e., in the time since the New York hospital records were first sampled for HMPS in 2018), including the shift to electronic health records and much care moving from the inpatient to ambulatory settings.

Pushing patient safety back to the top of the numerous urgent priorities

opens in a new tab or window, like supply-chain shortages and preparedness issues, facing healthcare systems today is a "sacred obligation" for all who sign up to "first do no harm," Berwick noted. "Without renewed board and executive leadership and accountability for safety and without concerted, persistent investment in and monitoring of change, a summary study 34 years from now may again look all too familiar, with millions upon millions of patients, families, and health care staff paying the price for inaction."

The updated HMPS was a retrospective look at 11 hospitals in Massachusetts with the same malpractice insurance carrier (a sponsor of the study) and selected to represent the range of large and small hospitals across three healthcare system. The random sample of admissions for adult patients occurring in 2018 excluded hospice, rehabilitation, psychiatric care, addiction treatment, and observation-only stays that didn't cross two midnights. A group of nine trained nurses reviewed the admissions records to identify possible adverse events, defined as "unintended physical injury resulting from or contributed to by medical care that requires additional monitoring, treatment, or hospitalization, or that results in death" and including both errors of omission and commission. After review of confirmed events, a random sample of 10% were reviewed by a second physician.

Adverse event type prevalence tracked with those previously reported

opens in a new tab or window, with drug events being most common (39.0% of all events), followed closely by surgical or procedural events (30.4%). Events associated with nursing care, including falls and pressure ulcers, accounted for 15.0% of the total, and healthcare-associated infectionsopens in a new tab or window represented 11.9%. The surgical events were most likely to be life-threatening, while the infections were most likely to be fatal.

Admissions involved at least one event that caused unnecessary harm but with rapid recovery -- defined as significant harm -- occurred in 18.6% of all admissions, while the rate of serious adverse events requiring substantial intervention or prolonged recovery was 7.5%, and 1.2% were life-threatening.

Of the seven deaths (0.2%) from adverse events, one was deemed to be preventable.

Patient characteristics associated with higher rates of adverse events included older age, male gender, Black or white versus Asian race, non-Hispanic versus Hispanic ethnicity, and private or Medicare insurance versus Medicaid.

Notably, the larger hospitals had higher adverse healthcare error adverse event rates than the smaller hospitals in the study. That variation from center to center "suggests that if hospitals had data that were more reliable and more routinely collected, it is possible that monitoring could be improved, adverse event rates could be reduced, and improvement strategies could be shared through careful study of interventions," the researchers wrote.

"Other key organizational elements such as safety culture and strong leadership with respect to safety and quality are also needed to advance performance," the team said. "Our findings are an urgent reminder to all health care professionals of the need for continuing improvement in the safety of the care we deliver."

Disclosures

The study was supported by a grant from the Controlled Risk Insurance Company and the Risk Management Foundation of the Harvard Medical Institutions.

Bates disclosed relationships with AESOP, CDI Negev, EarlySense, FeelBetter, Guided Clinical Solutions, IBM Watson, MDClone, and Valera Health.

Berwick disclosed no relevant conflicts of interest.

Primary Source

New England Journal of Medicine

Source Reference: opens in a new tab or windowBates DW, et al "The safety of inpatient health care" N Engl J Med 2023; DOI: 10.1056/NEJMsa2206117.

Secondary Source

New England Journal of Medicine

Source Reference: opens in a new tab or windowBerwick DM "Constancy of purpose for improving patient safety -- Missing in action" N Engl J Med 2023; DOI: 10.1056/NEJMe2213567.


https://www.medpagetoday.com/hospitalbasedmedicine/generalhospitalpractice/102594

How Many Times Do You Need to Get Out of Your Chair in an Otherwise Sedentary Day?

 Frequency and duration both play a role in the extent that an intervention to reduce sedentary time can improve cardiometabolic measures, a small randomized trial found.

Compared with uninterrupted sitting, light walking breaks of 5 minutes every half an hour significantly and acutely reduced glucose levels, while taking breaks less frequently -- once an hour -- did not confer such an effect, according to Keith Diaz, PhD, an exercise physiologist at Columbia University Irving Medical Center in New York City, and colleagues.

Meanwhile, drops in systolic blood pressure (BP) were achieved across sedentary break doses tested. Improvements were most prominent with light walks every 60 minutes for 1 minute (-5.2 mm Hg) and every 30 minutes for 5 minutes (-4.3 mm Hg). The magnitude of these BP reductions may translate into a 13% to 15% decrease in risk of cardiovascular disease if sustained over time, the authors reported in the journal Medicine & Science in Sports & Exercise

opens in a new tab or window.

"What we know now is that for optimal health, you need to move regularly at work, in addition to a daily exercise routine," said Diaz in a press releaseopens in a new tab or window. "While that may sound impractical, our findings show that even small amounts of walking spread through the work day can significantly lower your risk of heart disease and other chronic illnesses."

The Physical Activity Guidelines for Americans, last updated in 2018opens in a new tab or window, advised the public that any amount of physical activity is better than none and that there is benefit to increasing moderate to vigorous exercise and reducing time spent sedentary.

However, just how much people need to break from sedentary time was not addressed in the national recommendations.

"Importantly, our findings provide key dosing information necessary for the development of evidence-based quantitative guidelines that describe how often and for how long sedentary breaks should be taken when using light intensity, aerobic-based sedentary breaks," Diaz's group wrote.

"If we hadn't compared multiple options and varied the frequency and duration of the exercise, we would have only been able to provide people with our best guesses of the optimal routine," Diaz added.

The investigators had performed a randomized crossover study that had participants test five different exercise routines, 8 hours at a time, in random order on separate days, including:

  • One uninterrupted sedentary control condition
  • Light treadmill walks every 30 minutes for 1 minute
  • Light treadmill walks every 30 minutes for 5 minutes
  • Light treadmill walks every 60 minutes for 1 minute
  • Light treadmill walks every 60 minutes for 5 minutes
Out of 25 people screened, 11 who were relatively sedentary, older than 45, and without any pre-existing chronic medical conditions were selected to be randomized.

This cohort averaged 57 years of age; 54.5% were men and 35.3% were Black. The majority were normoglycemic (only one in the pre-diabetic range), and were roughly split between normotensive and prehypertensive/hypertensive at baseline.

Participants abstained from caffeine, alcohol, vitamins/supplements, and exercise for 48 hours prior to study visits and stayed on their usual medications. On the date of study visits, participants arrived in the morning after an overnight fast and had glucose and BP measured every 15 and 60 minutes, respectively.

Diaz's team acknowledged that the study did not analyze the chronic effects of sedentary breaks or more intense physical activity during breaks.

In addition, the small sample was due to the study being terminated early because of the COVID-19 pandemic, they noted.

Disclosures

The study was supported by institutional funding.

Diaz and colleagues had no conflicts of interest listed.

Primary Source

Medicine & Science in Sports & Exercise

Source Reference: opens in a new tab or windowDuran AT, et al "Breaking up prolonged sitting to improve cardiometabolic risk: dose-response analysis of a randomized cross-over trial" Med Sci Sports Exerc 2023; DOI: 10.1249/MSS.0000000000003109.


https://www.medpagetoday.com/primarycare/exercisefitness/102607

Alpha Tau at JPM

 Alpha Tau Medical is a biotech company working on new modes of focal alpha-radiation treatment for various cancers. The company’s delivery Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to release high-energy dosages over a range of just a few millimeters – giving a high level of precision that will target the tumor only while sparing nearby healthy tissues. Alpha DaRT is administered by inserting tiny amounts of radiu-224 directly into the tumor cells, where it will decay rapidly, releasing alpha particles directly into the cancer cells. These particles themselves have a short half-life, preventing their spread outside of the target area.

In recent updates, Alpha Tau has outlined several steps that have put the company on the track toward active clinical trials. In the UK, the company has received regulatory approval for a trial in the treatment of squamous cell carcinoma of the vulva, while in Canada, regulatory authorities have approved a second site for a clinical trial in the treatment of advanced pancreatic cancer.

The company has several anticipated milestones coming in the near-term, including an Israeli feasibility trial for the treatment of pancreatic tumors to start in 1Q23, and Canadian approval to start a feasibility trial in the treatment of liver cancer, also in 1Q23.

Ladenburg Thalmann analyst Jeffrey Cohen covers this early-stage biotech, and takes an upbeat stance, based on the quality of the program and the plethora of upcoming catalysts.

“DRTS has demonstrated competency and clinical execution, in our opinion. We also note the continued efforts around building a strong body of data to support the clinical and regulatory opportunities for the Alpha DaRT technology. Overall, we are encouraged by the progress to date and the multiple near-term milestones as well as potential catalysts. As such, we continue to view DRTS as an attractive investment opportunity compared to peers,” Cohen wrote.

In line with his optimistic approach, Cohen gives DRTS shares a Buy rating, and his $18 price target suggests an impressive 460% potential upside for the coming year. (To watch Cohen’s track record, click here)

Cohen is not the only analyst to see a solid upside here; all three of this stock’s recent reviews are positive, for a Strong Buy consensus rating. The stock is trading for $3.21, implies a gain of ~450% on the one-year horizon.

https://www.tipranks.com/news/article/2-strong-buy-penny-stocks-with-over-400-upside-on-the-horizon

18 YO Las Vegas HS Student "Suddenly And Unexpectedly" Dies Of Cardiac Arrest After Gym Class

 Either there is a new focus in media on reporting about the untimely deaths of athletes and young adults, or something very odd appears to be taking place across the country.

Either way, we are having difficulty keeping up with what now seems like daily headlines about young adults "dying suddenly" - and far too soon - from unexpected cardiac issues. And of course, the left-wing censor-machine remains on overdrive for anyone that dares the thought-crime of asking questions about the related causes of death. 

Recall, just yesterday, we wrote about 21 year old Air Force football player Hunter Brown, who suffered a "medical emergency" while walking to class on Monday of this week and passed away. This came just hours after the MMA world was shocked at the unexpected death of 18 year old Victoria Lee, a rising star on the the ONE Championship MMA promotion, just days after we highlighted Old Dominion basketball player Imo Essien collapsing on the court during the middle of a game and a little more than a week after NFL player Demar Hamlin collapsed on the field due to cardiac arrest after making what appeared to be a routine tackle. 

No sooner did we publish yesterday's article than another popped up in its place, with TODAY reporting on the story of a high school senior who "suffered cardiac arrest and was found unresponsive in the school bathroom" after gym class at Amplus Academy in Las Vegas.

18 year old Jordan Brister could not be saved by the time emergency personnel were alerted to his condition. A friend of his family wrote on a GoFundMe page for Brister that he "suddenly and unexpectedly suffered cardiac arrest while at school with no explanation as to why."

The page continued: "Words cannot express what the Brister family is going through and there will never be enough answers as to why this has happened. He was an amazing kid who loved life to the fullest."

"His family does not know what happened, other than his heart stopped, and he had no medical history and did not do drugs," another report said. 

Even more stunning is that, buried later in the TODAY article about Brister is the reveal that his deal happened the same week as the death of another Las Vegas High School student. Brister's collapse was on January 8, 2023, and another student, 16 year old Ashari Hughes, had died just three days prior "following a flag football game at Desert Oasis High School" and suffering a "medical episode". 

Dr. Adam Kean at Riley Hospital for Children in Indianapolis, of course, reminded TODAY that "sudden cardiac arrest is the leading cause of death in high-school athletes". But even he remarked on how rare it was: “Even though it is the No. 1 cause, it is remarkably rare, which is important. We estimate that one in 30,000 children die of cardiac arrest each year, and that sounds incredibly small. But that’s still around 2,000 children in the United States each year.”

Meanwhile, the Clark County Coroner’s Office "said the exact cause of Brister’s death is still under investigation".

https://www.zerohedge.com/markets/18-year-old-las-vegas-high-school-student-suddenly-and-unexpectedly-dies-cardiac-arrest-no